Invitae (NYSE:NVTA – Get Rating) had its price target decreased by Piper Sandler from $1.75 to $1.50 in a research report released on Monday, The Fly reports. A number of other analysts have also weighed in on the stock. StockNews.com began coverage on shares of Invitae in a research note on Thursday, March 16th. They […]
Invitae Co. (NYSE:NVTA – Get Rating) insider Robert L. Nussbaum sold 26,476 shares of the company’s stock in a transaction on Tuesday, May 16th. The shares were sold at an average price of $1.20, for a total value of $31,771.20. Following the completion of the sale, the insider now owns 576,431 shares of the company’s […]
Invitae Co. (NYSE:NVTA – Get Rating) CFO Yafei Wen sold 43,452 shares of Invitae stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $1.99, for a total value of $86,469.48. Following the transaction, the chief financial officer now directly owns 700,297 shares in the company, valued at […]
Invitae Co. (NYSE:NVTA – Get Rating) has been assigned a consensus recommendation of “Hold” from the twelve brokerages that are currently covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a sell rating and five have given a hold rating to the company. The average 12-month target price among brokers […]
Genetic testing company Natera Inc convinced a Delaware federal jury on Monday to award it $19.3 million in damages from Invitae Corp s ArcherDX for infringing patents related to cancer detection.. | May 15, 2023